News Interim report for the first nine months of 2022 Please read the full announcement in PDF Attachment 2022_27_Q32022_CompanyAnnouncement Continue Reading Previous Addex Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 11, 2022Next APEIRON Respiratory Therapies announces positive results from Phase I trial of inhaled APN01 Related Stories News Vocalbeats.AI Achieves ISO/IEC 42001 Certification, Reinforcing Responsible AI Governance News VideoGen Unveils Model 1, Its First AI Video Generation Model, and $1 Million in Free AI Credits News Callings.ai Launches Outplacement 2.0 at HR Tech 2026, Turning Employee Exits Into Lasting Talent Relationships News Cycode Expands Canadian Presence, Building on Global Momentum in Agentic Development Security News Splashtop Agentic Packr Automates App Packaging for Microsoft Intune News Kahuna Workforce Solutions Joins Infor Marketplace, Bringing Frontline Skills Intelligence to Infor HCM Customers
